Portfolio company
Anvil Diagnostics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops molecular blood tests to identify and quantify pathogens in hospitalised patients using digital PCR hardware.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Noscendo
This company develops bioinformatic software and diagnostic platforms to identify pathogens in bloodstream infections for hospitals and clinical laboratories.
Deepull
Deepull develops automated diagnostic systems that identify pathogens and antibiotic resistance directly from blood samples for healthcare providers treating sepsis and acute infections.
Nanopath
This company develops point-of-care molecular diagnostic tests and hardware for pelvic and gynecologic infections to provide rapid results for healthcare providers and their patients.
Pattern Diagnostics
This company develops single-cell microbiology systems for rapid pathogen identification and antibiotic susceptibility testing, serving hospital and clinical microbiology laboratories.
Molecular Stethoscope
This company develops blood-based liquid biopsy tests that analyse cell-free messenger RNA to help clinicians and researchers detect and monitor diseases.
Septest
This company develops point-of-need blood tests for healthcare professionals to rapidly identify infection and inflammation biomarkers in patients.
Pattern Biosciences
This company develops single-cell microbiology diagnostic systems for rapid bacterial identification and antibiotic susceptibility testing for clinical laboratories and hospital settings.
iFAST Diagnositcs
The company develops rapid antimicrobial susceptibility testing systems for hospitals and clinical laboratories to identify effective antibiotic treatments for bacterial infections.
